# EDGAR Filing Document

**Accession Number:** 0001357874
**File Stem:** 0001011438-25-000451
**Filing Date:** 2025-8
**Character Count:** 19646
**Document Hash:** c63558291474c617ead1e70f88076fb7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001011438-25-000451.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0001011438-25-000451

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250814

**DATE AS OF CHANGE**: 20250814

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PRECISION BIOSCIENCES INC
- **CENTRAL INDEX KEY:** 0001357874
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90975
- **FILM NUMBER:** 251219017

**BUSINESS ADDRESS:**
- **STREET 1:** 302 EAST PETTIGREW STREET
- **STREET 2:** SUITE A-100
- **CITY:** DURHAM
- **STATE:** NC
- **ZIP:** 27701
- **BUSINESS PHONE:** 919-314-5512

**MAIL ADDRESS:**
- **STREET 1:** 302 EAST PETTIGREW STREET
- **STREET 2:** SUITE A-100
- **CITY:** DURHAM
- **STATE:** NC
- **ZIP:** 27701
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Readout Capital, LP
- **CENTRAL INDEX KEY:** 0002063423

**ORGANIZATION NAME:**
- **EIN:** 922894661
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** 1630 COLUMBIA ROAD NW
- **STREET 2:** APT 418
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20009
- **BUSINESS PHONE:** 9179122289

**MAIL ADDRESS:**
- **STREET 1:** 1630 COLUMBIA ROAD NW
- **STREET 2:** APT 418
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20009

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Issuer:** PRECISION BIOSCIENCES INC

**Title of Class of Securities:** Common Stock, par value $0.000005 per share

**CUSIP Number:** 74019P207

**Date of Event Which Requires Filing of this Statement:** 06/30/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Readout Capital, LP | Names of Reporting Persons<br>Readout Capital, LP |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>200000 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>906437 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>200000 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>906437 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1106437 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1106437 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>9.3% | Percent of Class Represented by Amount in Row (9)<br>9.3% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

---

| 1. | Names of Reporting Persons<br>Readout Capital GP, LLC | Names of Reporting Persons<br>Readout Capital GP, LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>200000 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>906437 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>200000 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>906437 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1106437 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1106437 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>9.3% | Percent of Class Represented by Amount in Row (9)<br>9.3% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

---

| 1. | Names of Reporting Persons<br>ROC Holdings SPV II, LP | Names of Reporting Persons<br>ROC Holdings SPV II, LP |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>906437 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>906437 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>906437 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>906437 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>7.6% | Percent of Class Represented by Amount in Row (9)<br>7.6% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

---

| 1. | Names of Reporting Persons<br>Readout Holdings GP, LLC | Names of Reporting Persons<br>Readout Holdings GP, LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>906437 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>906437 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>906437 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>906437 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>7.6% | Percent of Class Represented by Amount in Row (9)<br>7.6% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

---

| 1. | Names of Reporting Persons<br>Matthew Smith | Names of Reporting Persons<br>Matthew Smith |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>X1 | Citizenship or Place of Organization<br>X1 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>212874 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>906437 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>212874 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>906437 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1119311 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1119311 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>9.4% | Percent of Class Represented by Amount in Row (9)<br>9.4% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

---

**Item 1(a). Name of Issuer:**
PRECISION BIOSCIENCES INC

**Item 1(b). Address of Issuer's Principal Executive Offices:**
302 East Pettigrew St., Suite A-100, Durham, North Carolina, 27701

**Item 2(a). Name of Person Filing:**
(i) Readout Capital, LP, (ii) Readout Capital GP, LLC, (iii) ROC Holdings SPV II, LP, (iv) Readout Holdings GP, LLC, and (v) Matthew Smith (collectively, the "Reporting Persons")

**Item 2(b). Address of Principal Business Office:**
For each of the Reporting Persons:  1630 Columbia Road NW, Unit 418, Washington, D.C. 20009

**Item 2(c). Citizenship:**
(i) Readout Capital, LP is a Delaware limited partnership, (ii) Readout Capital GP, LLC is a Delaware limited liability company, (iii) ROC Holdings SPV II, LP is a Delaware limited partnership, (iv) Readout Holdings GP, LLC is a Delaware limited liability company and (v) Matthew Smith is a United States citizen.

**Item 2(d). Title of Class of Securities:**
Common Stock, par value $0.000005 per share

**Item 2(e). CUSIP Number:**
74019P207

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

The information in Item 9 of the cover pages of this Schedule 13G for each of the Reporting Persons, which is as June 30, 2025, is incorporated herein by reference.  As of June 30, 2025, ROC Holdings SPV II, LP ("ROC SPV II") directly held 686,437 shares of Common Stock, par value $0.000005 per share ("Common Stock"), of Precision BioSciences, Inc. (the "Issuer") and warrants exercisable for 220,000 shares of Common Stock of the Issuer. Readout Holdings GP, LLC ("Readout Holdings GP") is the general partner of ROC SPV II and Readout Capital, LP ("Readout Capital") serves as investment manager for ROC SPV II.  Readout Capital GP, LLC ("Readout Capital GP") is the general partner of Readout Capital and Matthew Smith is the Manager of each of Readout Holdings GP and Readout Capital GP.  In addition, Readout Capital serves as the investment manager for a managed account that as of June 30, 2025, held 200,000 shares of Common Stock of the Issuer, and Readout Capital has been delegated voting and investment power over shares of Common Stock held by such managed account pursuant to an Investment Management Agreement.  As of June 30, 2025, Matthew Smith directly held 12,874 shares of Common Stock of the Issuer.

**(b) Percent of class:**

As of June 30, 2025, each of Readout Capital and Readout Capital GP may have been deemed to have beneficially owned 9.3% of the shares of Common Stock of the Issuer outstanding.  As of June 30, 2025, each of ROC SPV II and Readout Holdings GP may have been deemed to have beneficially owned 7.6% of the shares of Common Stock of the Issuer outstanding.  As of June 30, 2025, Matthew Smith may have been deemed to have beneficially owned 9.4% of the shares of Common Stock of the Issuer outstanding.  Such percentages are based on 11,636,981 shares of Common Stock of the Issuer outstanding as of June 30, 2025, as disclosed in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 7, 2025, plus 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025.

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

As of June 30, 2025, each of Readout Capital and Readout Capital GP may have been deemed to have had sole power to vote or to direct the vote of 200,000 shares of Common Stock. As of June 30, 2025, each of ROC SPV II and Readout Holdings GP may have been deemed to have had sole power to vote or direct the vote of 0 shares of Common Stock. As of June 30, 2025, Matthew Smith may have been deemed to have had sole power to vote or to direct the vote of 212,874 shares of Common Stock.

**(ii) Shared power to vote or to direct the vote:**

As of June 30, 2025, each of Readout Capital and Readout Capital GP may have been deemed to have had shared power to vote or to direct the vote of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025. As of June 30, 2025, each of ROC SPV II and Readout Holdings GP may have been deemed to have had shared power to vote or direct the vote of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025. As of June 30, 2025, Matthew Smith may have been deemed to have had shared power to vote or to direct the vote of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025.

**(iii) Sole power to dispose or to direct the disposition of:**

As of June 30, 2025, each of Readout Capital and Readout Capital GP may have been deemed to have had sole power to dispose or to direct the disposition of 200,000 shares of Common Stock. As of June 30, 2025, each of ROC SPV II and Readout Holdings GP may have been deemed to have had sole power to dispose or direct the disposition of 0 shares of Common Stock. As of June 30, 2025, Matthew Smith may have been deemed to have had sole power to dispose or to direct the disposition of 212,874 shares of Common Stock.

**(iv) Shared power to dispose or to direct the disposition of:**

As of June 30, 2025, each of Readout Capital and Readout Capital GP may have been deemed to have had shared power to dispose or to direct the disposition of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025. As of June 30, 2025, each of ROC SPV II and Readout Holdings GP may have been deemed to have had shared power to dispose or direct the disposition of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025. As of June 30, 2025, Matthew Smith may have been deemed to have had shared power to dispose or to direct the disposition of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025.

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

The information in Item 4 is incorporated herein by reference.

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Readout Capital, LP**

**Date:** 08/14/2025

**By:** /s/ Matthew Smith

**Name & Title:** Matthew Smith/Manager, Readout Capital GP, LLC, its General Partner

**Readout Capital GP, LLC**

**Date:** 08/14/2025

**By:** /s/ Matthew Smith

**Name & Title:** Matthew Smith/Manager

**ROC Holdings SPV II, LP**

**Date:** 08/14/2025

**By:** /s/ Matthew Smith

**Name & Title:** Matthew Smith/Manager, Readout Holdings GP, LLC, its General Partner

**Readout Holdings GP, LLC**

**Date:** 08/14/2025

**By:** /s/ Matthew Smith

**Name & Title:** Matthew Smith/Manager

**Matthew Smith**

**Date:** 08/14/2025

**By:** /s/ Matthew Smith

**Name & Title:** Matthew Smith/Self